Similar articles

• Concomitant IDH wild-type glioblastoma and IDH1-mutant anaplastic astrocytoma in a patient with constitutional mismatch repair deficiency syndrome.

  Galuppini F, Opocher E, Tabori U, Mammi I, Edwards M, Campbell B, Kelly J, Viel A, Quaia M, Rivieri F, D'Avella D, Arcella A, Giangaspero F, Fassan M, Gardiman MP. Galuppini F, et al. Neuropathol Appl Neurobiol. 2018 Feb;44(2):233-239. doi: 10.1111/nan.12450. Neuropathol Appl Neurobiol. 2018. PMID: 29130549 No abstract available.
• Roles of the functional loss of p53 and other genes in astrocytoma tumorigenesis and progression.

  Nozaki M, Tada M, Kobayashi H, Zhang CL, Sawamura Y, Abe H, Ishii N, Van Meir EG. Nozaki M, et al. Neuro Oncol. 1999 Apr;1(2):124-37. doi: 10.1093/neuonc/1.2.124. Neuro Oncol. 1999. PMID: 11550308 Free PMC article. Review.
• Oncogenes: cause or consequence in the development of glial tumors.

  Akbasak A, Sunar-Akbasak B. Akbasak A, et al. J Neurol Sci. 1992 Sep;111(2):119-33. doi: 10.1016/0022-510x(92)90060-x. J Neurol Sci. 1992. PMID: 1331337 Review.
• Molecular biology of malignant degeneration of astrocytoma.

  Furnari FB, Huang HJ, Cavenee WK. Furnari FB, et al. Pediatr Neurosurg. 1996;24(1):41-9. doi: 10.1159/000121013. Pediatr Neurosurg. 1996. PMID: 8817614 Review.
• The molecular biology and molecular genetics of astrocytic neoplasms.

  Wong AJ, Zoltick PW, Moscatello DK. Wong AJ, et al. Semin Oncol. 1994 Apr;21(2):139-48. Semin Oncol. 1994. PMID: 8153660 Review. No abstract available.